Apart from mortality, stroke is one of the leading causes of disability worldwide [63], so using ATX–LPA axis inhibitors as interventions or adjuvants could be helpful in stabilizing stroke patient conditions for better outcomes. This evidence concerns the gene ENPP2 and Stroke.